Cargando…
Newly Emerged Antiviral Strategies for SARS-CoV-2: From Deciphering Viral Protein Structural Function to the Development of Vaccines, Antibodies, and Small Molecules
Coronavirus disease 2019 (COVID-19) caused by the infection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become the most severe health crisis, causing extraordinary economic disruption worldwide. SARS-CoV-2 is a single-stranded RNA-enveloped virus. The process of viral replica...
Autores principales: | Zhang, Chunye, Yang, Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9181103/ https://www.ncbi.nlm.nih.gov/pubmed/35682761 http://dx.doi.org/10.3390/ijms23116083 |
Ejemplares similares
-
A strategy for evaluating potential antiviral resistance to small molecule drugs and application to SARS-CoV-2
por: Sargsyan, Karen, et al.
Publicado: (2023) -
Evaluation of antiviral drugs against newly emerged SARS-CoV-2 Omicron subvariants
por: Cho, Junhyung, et al.
Publicado: (2023) -
Deciphering Fc-mediated Antiviral Antibody Functions in Animal Models
por: Schmaljohn, Alan L., et al.
Publicado: (2019) -
Deciphering antiviral efficacy of malaria box compounds against malaria exacerbating viral pathogens- Epstein Barr virus and SARS-CoV-2, an in silico study
por: Indari, Omkar, et al.
Publicado: (2022) -
Emerging mutations in the SARS-CoV-2 variants and their role in antibody escape to small molecule-based therapeutic resistance
por: Chakraborty, Chiranjib, et al.
Publicado: (2022)